New study zeroes in on genetic roots of Alzheimer's

April 10, 2007

Scientists have known for more than a decade that individuals with a certain gene are at higher risk for developing Alzheimer's disease. Now a new study helps explain why this is so.

The research, led by scientists at the Oklahoma Medical Research Foundation (OMRF), has uncovered a molecular mechanism that links the susceptibility gene to the process of Alzheimer's disease onset. The findings appear in the April 11 issue of The Journal of Neuroscience and may lead to new pathways for development of Alzheimer's therapeutics.

Approximately 15 percent of the population carries a gene that causes their bodies to produce a lipoprotein--a combination of fat and protein that transports lipids (fats) in the blood--known as apolipoprotein (Apo) E4. Studies have found that those who inherit the E4 gene from one parent are three times more likely than average to develop Alzheimer's, while those who get the gene from both parents have a tenfold risk of developing the disease.

In the new study, OMRF's Jordan J.N. Tang, Ph.D., and his colleagues discovered that ApoE4 (along with other apolipoproteins) attaches itself to a particular receptor on the surface of brain cells. That receptor, in turn, adheres to a protein known as amyloid precursor protein. The brain cells then transport the entire protein mass inside.

Once inside, cutting enzymes--called proteases--attack the amyloid precursor protein. These cuts create protein fragments that, when present in the brain for long periods of time, are believed to cause the cell death, memory loss and neurological dysfunction characteristic of Alzheimer's.

Although researchers have known for more than a decade that ApoE4 was involved--somehow--in development of Alzheimer's, Tang's new study is the first to connect the process of protein fragment formation to ApoE4.

While roughly 1 in 7 people carry the E4 gene, the remainder of the population carry only two variations--known as E2 and E3--of that gene. These individuals have a markedly lower incidence of Alzheimer's than those who carry the E4 gene. The new study found that ApoE4 produced more protein fragments than did E2 or E3.

"ApoE4 apparently interacts better with the receptor than its cousins," said Tang. "This may explain why people who carry the E4 gene have a higher risk of developing Alzheimer's."

"These findings may allow us to investigate the possibility of therapeutic intervention at different points in the process," said Tang. For example, he said, such efforts might focus on developing a compound to interfere with the receptor's ability to adhere to ApoE4.

"There currently is no effective treatment for Alzheimer's disease, so we must explore every possible option to find a way to stop it," he said.

"Dr. Tang's study shows a beautiful biochemical connection between a genetic risk factor and the development of a disease," said OMRF President Stephen Prescott, M.D. "This work opens the door to the development of alternate methods for treating--and perhaps even preventing--Alzheimer's."

ApoE4 also has been linked to coronary artery disease. "Ultimately, this work could pave the way for similar study of the pathogenesis of other diseases," said Prescott.
-end-
The study was funded by the National Institute on Aging and the Alzheimer's Association and was done in collaboration with the University of Alabama at Birmingham.

At OMRF, Tang heads OMRF's protein studies research program and holds the J.G. Puterbaugh Chair in Medical Research. His work with proteases has made important contributions to the study of gastric enzymes, HIV and, most recently, Alzheimer's disease.

In 1999, Tang and his colleagues at OMRF identified the protease (known as memapsin 2) believed to be the culprit behind Alzheimer's. After cloning that protease, he led a team of researchers that created an inhibitor to halt the enzyme's cutting action. That work earned Tang the Alzheimer's Association's Pioneer Award, and an experimental drug based on Tang's inhibitor currently is undergoing pre-clinical trials.

Scientific images showing the biochemical processes described in this press release, along with photos of Jordan Tang, are available upon request.

About Alzheimer's

Alzheimer's disease is a neurological disorder characterized by slow, progressive memory loss due to the gradual death of brain cells. According to the Alzheimer's Association, the disease affects more than 5 million Americans, including nearly half the population over the age of 85.

About OMRF

Chartered in 1946, OMRF (www.omrf.org) is an independent, nonprofit biomedical research institute dedicated to understanding and developing more effective treatments for human disease. Its scientists focus on such critical research areas as Alzheimer's disease, cancer, lupus and cardiovascular disease. Discoveries at OMRF have given birth to a pair of FDA-approved drugs, and it is home to Oklahoma's only member of the National Academy of Sciences.

Oklahoma Medical Research Foundation

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.